Atlas Trials

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Clinical trial NCT02640729 · COMPLETED

Trial details

NCT number
NCT02640729
Sponsor
Axovant Sciences Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lewy Body DementiaVisual Hallucinations
Start date
2015-12-01
Primary completion
2017-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.